← Back to patent-cliff list
CAS 100-97-0
1,3,5,7-tetraazaadamantane
Codes：LEVO-014
Application context (from source-drug indications)
重度抑郁症盐酸左米那普仑缺血性卒中盐酸左米那普仑抑郁盐酸左米那普仑
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸左米那普仑Levomilnacipran Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
LEVO-013→1,3,5,7-tetraazaadamantane→1-(((1R,2S)-2-(diethylcarbamoyl)-2-phenylcyclopropyl)methyl)-1,3,5,7-tetraazaadamantan-1-ium bromide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.